-
公开(公告)号：US20230212299A1
公开(公告)日：2023-07-06
申请号：US18069511
申请日：2022-12-21
发明人： Brian Wong , Julie Hambleton , Robert Sikorski , Emma Masteller , Kevin Hestir , David Bellovin , Katherine E. Lewis
CPC分类号： C07K16/2863 , C07K16/2896 , A61P35/00 , C07K2317/565
摘要： Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
-
公开(公告)号：US10730949B2
公开(公告)日：2020-08-04
申请号：US16015371
申请日：2018-06-22
摘要： Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
-
公开(公告)号：US20180094067A1
公开(公告)日：2018-04-05
申请号：US15680664
申请日：2017-08-18
发明人： Brian Wong , Julie Hambleton , Robert Sikorski , Emma Masteller , Kevin Hestir , David Bellovin , Katherine E. Lewis
CPC分类号： C07K16/2866 , A61K2039/505 , A61K2039/507 , A61K2039/54 , A61K2039/545 , C07K16/2803 , C07K16/2818 , C07K16/3046 , C07K16/3069 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
摘要： Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
-
14.发明申请公开(公告)号：US20170145102A1
公开(公告)日：2017-05-25
申请号：US15358756
申请日：2016-11-22
发明人： Kristen Pierce , Janine Powers , Servando Palencia , Robert Sikorski , Majid Ghoddusi , Kartik Krishnan
CPC分类号： C07K16/2863 , A61K2039/505 , A61K2039/507 , A61K2039/55 , C07K16/2818 , C07K16/2896 , C07K16/3015 , C07K16/3023 , C07K16/303 , C07K16/3038 , C07K16/3046 , C07K16/3069 , C07K16/3084 , C07K2317/34 , C07K2317/41 , G01N33/5091 , G01N33/57407 , G01N33/57446 , G01N33/57492 , G01N2333/71 , G01N2800/52
摘要： Provided herein are uses of fibroblast growth factor receptor 2 (FGFR2) inhibitors in cancer treatment, in some cases in combination with immune stimulating agents, such as inhibitors of PD-1 or PD-L1. In some embodiments, FGFR2 inhibitors may comprise FGFR2 antibodies or FGFR2 extracellular domain (ECD) polypeptides, or FGFR2 ECD fusion molecules comprising an FGFR2 ECD and a fusion partner. In some embodiments, PD-1/PD-L1 inhibitors may comprise anti-PD-1 antibodies such as antibodies that bind to PD-1 or to PD-L1 and inhibit interactions between these proteins, as well as PD-1 fusion proteins or polypeptides.
-
公开(公告)号：US20160185869A1
公开(公告)日：2016-06-30
申请号：US14976346
申请日：2015-12-21
发明人： Robert Sikorski , Julie Hambleton , Neil Sankar
IPC分类号： C07K16/28
CPC分类号： C07K16/2866 , A61K2039/505 , A61K2039/545 , C07K2317/24 , C07K2317/34 , C07K2317/76 , C07K2317/92
摘要： Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
摘要翻译： 提供了结合集落刺激因子1受体（CSF1R）的抗体治疗色素沉着绒毛结节滑膜炎（PVNS）的方法。
-
16.发明授权公开(公告)号：US11447553B2
公开(公告)日：2022-09-20
申请号：US15358756
申请日：2016-11-22
发明人： Kristen Pierce , Janine Powers , Servando Palencia , Robert Sikorski , Majid Ghoddusi , Kartik Krishnan
IPC分类号： C07K16/28 , C07K16/30 , A61K39/00 , G01N33/50 , G01N33/574
摘要： Provided herein are uses of fibroblast growth factor receptor 2 (FGFR2) inhibitors in cancer treatment, in some cases in combination with immune stimulating agents, such as inhibitors of PD-1 or PD-L1. In some embodiments, FGFR2 inhibitors may comprise FGFR2 antibodies or FGFR2 extracellular domain (ECD) polypeptides, or FGFR2 ECD fusion molecules comprising an FGFR2 ECD and a fusion partner. In some embodiments, PD-1/PD-L1 inhibitors may comprise anti-PD-1 antibodies such as antibodies that bind to PD-1 or to PD-L1 and inhibit interactions between these proteins, as well as PD-1 fusion proteins or polypeptides.
-
17.发明申请公开(公告)号：US20210317219A1
公开(公告)日：2021-10-14
申请号：US17183734
申请日：2021-02-24
发明人： Julie Hambleton , Emma Masteller , James Zanghi , Robert Sikorski , Hong Xiang
IPC分类号： C07K16/28
摘要： Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided. Such methods include, but are not limited to, methods of treating rheumatoid arthritis.
-
公开(公告)号：US20210009700A1
公开(公告)日：2021-01-14
申请号：US16911806
申请日：2020-06-25
IPC分类号： C07K16/28
摘要： Methods of treating pigmented villonodular synovitis (PVNS) with antibodies that bind colony stimulating factor 1 receptor (CSF1R) are provided.
-
公开(公告)号：US20210009697A1
公开(公告)日：2021-01-14
申请号：US16646690
申请日：2018-09-12
发明人： Katherine E. Lewis , Serena Kimi Perna , Michael Carleton , Ke Xu , Penny Phillips , Dimple Pandya , Brian Wong , Julie Hambleton , Robert Sikorski , Emma Masteller , Kevin Hestir , David Bellovin , Janine Powers , Ernestine Lee
IPC分类号： C07K16/28 , A61K31/7068 , A61K31/513 , A61K39/395 , A61K31/337 , A61K47/69 , A61K47/64 , C12Q1/6886 , A61P35/00
摘要： The present invention relates to methods of treating pancreatic cancer with particular dosage regimes of antibodies that bind colony stimulating factor 1 receptor (CSF1R) (e.g. cabiralizumab) in combination with antibodies that bind programmed cell death 1 (PD-1) (e.g. nivolumab).
-
公开(公告)号：US20190202921A1
公开(公告)日：2019-07-04
申请号：US16243510
申请日：2019-01-09
发明人： Brian Wong , Julie Hambleton , Robert Sikorski , Emma Masteller , Kevin Hestir , David Bellovin , Katherine E. Lewis
CPC分类号： C07K16/2866 , A61K2039/505 , A61K2039/507 , A61K2039/54 , A61K2039/545 , C07K16/2803 , C07K16/2818 , C07K16/3046 , C07K16/3069 , C07K2317/24 , C07K2317/33 , C07K2317/565 , C07K2317/76 , C07K2317/90 , C07K2317/92
摘要： Methods of treating cancer with antibodies that bind colony stimulating factor 1 receptor (CSF1R) in combination with PD-1/PD-L1 inhibitors are provided.
-
-
-
-
-
-
-
-
-
搜索结果
22 条记录 (耗时 0.028 秒)
